Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Digestive Diseases has published significant clinical results demonstrating high efficacy of fecal microbiota transplantation in recurrent CDI and promising outcomes in ulcerative colitis and autism-related GI symptoms. It has also developed highly effective second-line and third-line regimens for H. pylori eradication (>96% success rate).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Digestive Diseases.